TrialRheumatology (Oxford, England)2021

Sub-setting systemic lupus erythematosus by combined molecular phenotypes defines divergent populations in two phase III randomized trials.

Michelle Petri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.